BioCentury
ARTICLE | Company News

Bostwick, Metabolon sales and marketing update

November 11, 2013 8:00 AM UTC

Bostwick will exclusively market Metabolon's Prostarix prostate cancer diagnostic in the U.S. The test is a non-invasive test that quantifies sarcosine and other biomarkers excreted into urine to stra...